Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,995 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Variation in use of neuroimaging in the care of infants undergoing subspecialty evaluations for abuse: A multicenter study.
Alpert E, Wood JN, Shults J, Lindberg DM, Campbell KA, Bhatia A, Anderst JD, Bachim A, Berger RP, Brink FW, Frasier LD, Harper N, Laub N, Melville J, Leonard J, Henry MK. Alpert E, et al. Among authors: leonard j. Acad Pediatr. 2024 Oct 25:S1876-2859(24)00543-6. doi: 10.1016/j.acap.2024.10.009. Online ahead of print. Acad Pediatr. 2024. PMID: 39490894
Sociodemographic Factors Influencing Access to Chimeric Antigen T-Cell Receptor Therapy for Patients With Non-Hodgkin Lymphoma.
Khare S, Williamson S, O'Barr B, Schachter L, Chen A, Hayes-Lattin B, Leonard J, Desai A, Ferreira-Gandolfo P, Christmas K, Lackey D, Maziarz RT, Nemecek ER. Khare S, et al. Among authors: leonard j. Clin Lymphoma Myeloma Leuk. 2024 Sep 27:S2152-2650(24)02355-3. doi: 10.1016/j.clml.2024.09.010. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39426942
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL.
Roloff GW, Aldoss I, Kopmar NE, Lin C, Dekker SE, Gupta VK, O'Connor TE, Jeyakumar N, Muhsen IN, Valtis Y, Ahmed N, Zhang A, Miller K, Dykes KC, Ahmed M, Chen EC, Mercadal S, Schwartz M, Tracy SI, Dholaria B, Mukherjee A, Battiwalla M, Logan AC, Ladha A, Guzowski C, Hoeg RT, Hilal T, Moore J, Connor MP, Hill LC, Tsai SB, Sasine JP, Solh MM, Kota VK, Koura D, Veeraputhiran M, Leonard JT, Frey NV, Park JH, Luskin MR, Bachanova V, Galal A, Pullarkat V, Stock W, Cassaday RD, Shah BD, Faramand R, Muffly L; ROCCA Consortium. Roloff GW, et al. Among authors: leonard jt. J Clin Oncol. 2024 Oct 17:JCO2400321. doi: 10.1200/JCO.24.00321. Online ahead of print. J Clin Oncol. 2024. PMID: 39418622
The Role of CAR T-Cell Therapy in Relapsed/Refractory Adult B-ALL.
Othman T, Logan AC, Muffly L, Leonard J, Park J, Shah B, Aldoss I. Othman T, et al. Among authors: leonard j. J Natl Compr Canc Netw. 2024 Oct;22(8):e247065. doi: 10.6004/jnccn.2024.7065. J Natl Compr Canc Netw. 2024. PMID: 39413830 Review.
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.
Herrera AF, LeBlanc M, Castellino SM, Li H, Rutherford SC, Evens AM, Davison K, Punnett A, Parsons SK, Ahmed S, Casulo C, Bartlett NL, Tuscano JM, Mei MG, Hess BT, Jacobs R, Saeed H, Torka P, Hu B, Moskowitz C, Kaur S, Goyal G, Forlenza C, Doan A, Lamble A, Kumar P, Chowdhury S, Brinker B, Sharma N, Singh A, Blum KA, Perry AM, Kovach A, Hodgson D, Constine LS, Shields LK, Prica A, Dillon H, Little RF, Shipp MA, Crump M, Kahl B, Leonard JP, Smith SM, Song JY, Kelly KM, Friedberg JW. Herrera AF, et al. Among authors: leonard jp. N Engl J Med. 2024 Oct 17;391(15):1379-1389. doi: 10.1056/NEJMoa2405888. N Engl J Med. 2024. PMID: 39413375 Free PMC article. Clinical Trial.
2,995 results